GlassScriptPhysician profile
James D Miller
NPI 1578818779
$38,054.20
in general payments reported to CMS, 2019-2025
12 companies · $15K in 2025
The $15K reported for 2025 was more than what 89% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,141 · 2020: $555 · 2021: $1,973 · 2022: $13K · 2023: $2,992 · 2024: $3,311 · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $12K · Travel and Lodging: $4,586 · Food and Beverage: $4,294.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $11,990.00 |
| Travel and Lodging | $4,586.32 |
| Food and Beverage | $4,293.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $23,573.48 | 2019-2025 | Mako, Aequalis, Insignia |
| Arthrex, INC. | $9,172.10 | 2021-2024 | |
| Cdc Medical LLC | $3,020.64 | 2021-2024 | |
| Medtronic USA, INC. | $1,207.95 | 2019-2020 | |
| Stimwave Technologies Incorporated | $249.52 | 2019-2021 | |
| Zimmer Biomet Holdings, INC. | $223.31 | 2019 | |
| Smith+Nephew, INC. | $147.50 | 2024 | Pico 14, Pico 7 |
| Becton, Dickinson and Company | $146.01 | 2022 | |
| Abbott Laboratories | $138.09 | 2020 | |
| Medtronic, INC. | $135.15 | 2021-2023 | Plasmablade(Tm) |
| Sientra, INC. | $28.31 | 2022 | |
| Pacira Therapeutics, INC. | $12.14 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.